Status:
UNKNOWN
Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Severe Alcoholic Hepatitis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Severity of alcoholic hepatitis is defined by Maddrey's discriminant function, value of 32 or higher indicates severe alcoholic hepatitis that carries an adverse prognosis with one month mortality of ...
Detailed Description
Study Design- Single center, Open label, Randomized controlled trial * According to current protocol, we discontinue the treatment after 28 days, it improve the mortality rate in severe alcoholic pat...
Eligibility Criteria
Inclusion
- Persistence of mDF \> 32 at day 28 of steroids.
Exclusion
- Active infection
- Uncontrolled sugars
- No consent
Key Trial Info
Start Date :
November 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 27 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06155760
Start Date
November 25 2023
End Date
February 27 2025
Last Update
December 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Liver & Biliary Sciences (ILBS)
New Delhi, National Capital Territory of Delhi, India, 110070